- delayed kidney development / MGI
- small kidney / MGI
- renal hypoplasia / MGI
- decreased renal glomerulus number / MGI
- impaired branching involved in ureteric bud morphogenesis / MGI
- neonatal lethality, complete penetrance / MGI
- embryonic lethality during organogenesis, incomplete penetrance / MGI
- abnormal ureteric bud tip morphology / MGI
B6.129-Wnt11tm1Amc/Oulu
Status | Available to order |
EMMA ID | EM:11255 |
International strain name | B6.129-Wnt11tm1Amc/Oulu |
Alternative name | Wnt11 knock-out |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Wnt11tm1Amc, |
Gene/Transgene symbol | Wnt11 |
Information from provider
Provider | Seppo Vainio |
Provider affiliation | Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu |
Additional owner | Andrew McMahon, University of Southern California, US |
Genetic information | The gene was disrupted by replacement of exons 4 and 5 with a PGK-neo cassette via homologous recombination. RT-PCR analysis of RNA from homozygous mutant animals revealed a truncated transcription product predicted to encode 28 N-terminal amino acids. This mutant protein is expected to be non-functional. |
Phenotypic information | Homozygous:Mortality/aging: The presence of the Wnt11 null allele in the C57BL/6 background partially overcomes the in utero lethality reported in the SV129 background. 1/3 of the Wnt11-/- mice with this inbred background survives to postnatal stages. Many of them also reach adulthood. The number of the surviving Wnt11-/- mice drops by around 50% by the age of 4–6 weeks. An additional reduction of 10% takes place by the age of 12 months. The proportion of female to male C57BL/6 Wnt11-/- survivors remains unchanged. Renal/urinary system: Hypoplastic kidneys. Glomerular cysts. Reduced amount of glomeruli. Compromised kidney function.Heterozygous:Mice heterozygous for this targeted mutation are viable and fertile with normal kidney size and histology. |
Breeding history | A targeting vector was designed to replace exons 4 and 5 of the endogenous gene with a PGK-neo cassette. This construct was microinjected into (129X1/SvJ x 129S1/Sv)F1-derived R1 embryonic stem (ES) cells. Correctly targeted ES cells were injected into blastocysts. Chimeric mice were bred to "129 substrain AV3" inbred mice (129X1/SvJ). Heterozygous mice were maintained and expanded on this same genetic background (129X1/SvJ) prior to crossing to C57BL/6JOlaHsd and from 2014 to C57BL/6N (5 generations). Totally over 10 generations in C57 background. |
References |
|
Homozygous fertile | not known |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | University of Oulu, Oulu, Finland |
Animals used for archiving | heterozygous C57BL/6NCrl |
Disease and phenotype information
MGI phenotypes (allele matching)
Literature references
- Impairment of Wnt11 function leads to kidney tubular abnormalities and secondary glomerular cystogenesis.;Nagy Irina I, Xu Qi, Naillat Florence, Ali Nsrein, Miinalainen Ilkka, Samoylenko Anatoly, Vainio Seppo J, ;2016;BMC developmental biology;16;30; 27582005
- Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development.;Majumdar Arindam, Vainio Seppo, Kispert Andreas, McMahon Jill, McMahon Andrew P, ;2003;Development (Cambridge, England);130;3175-85; 12783789
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).